Product Overview
[Drug Name]
Generic Name: Lacidipine Dispersible Tablets
Trade Name: Beiping
English Name: Lacidipine Dispersible Tablets
Chinese Pinyin: LaXiDiPingFenSanPian
[Ingredients]
Lacidipine. Chemical Name: (±)-2,6-Dimethyl-4-2-[(E)-2-(tert-butyloxycarbonyl)-vinyl]phenyl-1,4-dihydro-3,5-pyridinedicarboxylic acid diethyl ester. Molecular Weight: C26H33NO6
[Properties]
This product is a film-coated tablet that appears off-white after removal of the coating.
[Indications]
No data available.
[Dosage and Administration]
The initial dose is 2 mg once daily. It should be taken at the same time each day, preferably in the morning. Treatment of hypertension should be tailored to the severity of the condition and individual patient needs.
[Adverse Reactions]
Data from large-scale clinical studies (both internal and public) have been used to determine the frequency of adverse events, ranging from very common to uncommon.
[Contraindications]
This product is contraindicated in patients with allergies to any of the ingredients. Like other dihydropyridines, lacidipine is contraindicated in patients with severe aortic stenosis.
[Precautions]
Specific studies have shown that lacidipine does not affect sinus node automaticity or prolong conduction time within the atrioventricular node. However, the theoretical effects of calcium antagonists on sinus and atrioventricular node activity should be noted. Therefore, this product should be used with caution in patients with abnormal sinus and atrioventricular node activity. Please read the package insert carefully and use as directed by your doctor.
[Use in Special Populations]
Precautions for children: Not yet available.
Precautions for pregnancy and lactation: Not yet available.
Precautions for the elderly: Not yet available.
[Drug Interactions]
This product may produce additive antihypertensive effects when used in combination with other medications, including antihypertensive drugs such as diuretics, beta-blockers, or angiotensin-converting enzyme inhibitors. Concomitant use with cimetidine may increase the blood concentration of this product.
[Pharmacological Action]
Lacidipine is a highly specific and potent calcium ion antagonist with high selectivity for calcium channels in vascular smooth muscle. Its primary effects are dilation of peripheral arterioles, reduction of peripheral vascular resistance, and lowering of blood pressure.
[Storage] Sealed.
[Specification] 4mg x 21 tablets
[Packaging] Box
[Expiration Date] 24 months
[Approval Number] National Medicine Standard H20130129
[Manufacturer] Zhejiang Beide Pharmaceutical Co., Ltd.
